Make your money go further for just 25p per day

Novacyt: shares take a beating

09/04/2021 · Novacyt SA (NCYT) 

AIM UK

Comments (1) Email Print
Share
Covid test image

AIM’s top performer in 2020 has fallen back to earth after a disappointing trading update. Are the shares now a bargain or is there more trouble ahead? We offer our thoughts on this amazing little business.

The share price of Novacyt (LON: NCYT), the clinical diagnostics specialist and AIM’s top performer in 2020, tumbled 40% today on news that it is dispute with Department of Health and Social Care (DHSC).

Background

On 29 September 2020, Novacyt announced a second supply contract with the DHSC for its exsig®COVID-19 Direct kits and other products. In an earlier trading update on 29 January 2021, it explained it was in active discussions with the DHSC regarding an…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login

Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Novacyt SA

A refocused business delivers

30/09/2022 · Company Insights

Having survived a near death experience several years ago, a manufacturer of specialist industrial equipment covered…

Better than expected

17/06/2022 · Company Insights

Some welcome good news at last for shareholders in this provider of online competitions to win…

More Company Insights

Strong growth | Exceptional ambiguities | Dividend delights

12/03/2025 · Cambridge Cognition · Craneware · Facilities By ADF · GlobalData · Kitwave Group · Nichols · Somero Enterprises

Stonking Small Caps: new partnership

10/03/2025 · PCI- PAL

15% dividend yield - too good to be true?

06/03/2025 · Impax Asset Management · Kitwave Group · Netcall · Quartix Technologies

More on Novacyt SA

A refocused business delivers
Better than expected
Upgrades in the AIM sell-off
A Covid tester is back in favour

More Company Insights

Strong growth | Exceptional ambiguities | Dividend delights
Stonking Small Caps: new partnership
15% dividend yield - too good to be true?

Search for AIM companies qualifying for relief from Inheritance Tax!

Use our unique screening tool to identify Inheritance Tax planning AIM companies

This search will take you to the separate AIMsearch web site which requires a different user name and password to this Investor's Champion site.
Investor’s Champion, making your money go further.

Sign-up to our free email updates

SIGN UP

ABOUT INVESTORS CHAMPION

Investor's Champion offers objective, incisive and forthright comment on quoted companies and personal finance. Our content addresses what we believe are the key issues in helping make your money go further.

Investor's Champion is a registered trade mark of Investors Champion Ltd. Investor's Champion Limited is a company registered in England and Wales under number 03577867 whose registered office is at c/o Cox Costello & Horne, Batchworth Lock House, 99 Church Street, Rickmansworth, WD3 1JJ.

All rights reserved. © 2007 - 2025